Currently, the digital rectal examination (DRE) and the prostate specific antigen (PSA) blood test are the two screening methods of PCa recommended by the American Cancer Society (Smith et al., 2004[30]). This evidence concerns the gene KLK3 and posterior cortical atrophy.